Stephane Bancel
Stephane Bancel is the CEO of Moderna, a biotechnology company that became widely known for its development of mRNA vaccines, particularly during the COVID-19 pandemic. Under his leadership, Moderna has been at the forefront of mRNA technology, which has shown promise in responding to various infectious diseases. Recently, Bancel commented on the termination of a $590 million contract with the U.S. Department of Health and Human Services for a bird flu vaccine, expressing disappointment but also highlighting the positive immune response observed in early trials.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 7.00 | 0.03% | +0% | 331,002,651 | 104,220 | $21,000,000 | 6,612$ |
| France | 1 | 7.00 | 0.08% | +0% | 65,273,511 | 49,865 | $2,700,000 | 2,063$ |
| India | 1 | 8.00 | 0.07% | +0% | 1,380,004,385 | 960,337 | $2,900,000 | 2,018$ |
| Totals | 3 | 1,776,280,547 | 1,114,422 | $26,600,000 | 10,693$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
India:
Stéphane Bancel is the Chief Executive Officer of Moderna and commented on the FDA approval of their new COVID-19 vaccine.
8
France:
Stéphane Bancel is the CEO of Moderna and commented on the robust immune response observed in a clinical trial.
7
United States:
Moderna CEO Stephane Bancel commented on the immune response of their vaccine.
7